Latest news
Immunohistochemical Expression of Programmed Death-Ligand 1 (PD-L1) in Breast Carcinoma and Its Correlation With Estrogen Receptor, Progesterone Receptor and HER2/neu Status: A Single-Centre Study From Central India - CureusCureus · Wed, 05 Aug 2026 14:36:24 GMTMicronised Progesterone Adds No Ki67 Benefit to Letrozole in ER+ Breast Cancer - Targeted OncologyTargeted Oncology · Wed, 29 Jul 2026 07:00:00 GMT